Why Quest Diagnostics Holdings Stock Dropped Today
Yahoo Finance ·
Medical testing giant Quest Diagnostics ( DGX -5.03% ) stock slipped 5.1% through 11:30 a.m. Tuesday, after the Centers for Medicare & Medicaid Services (CMS) disclosed Monday that they've been paying about 16% more for lab work than private insurers pay. Effective Jan. 1, 2027, CMS says it will cut reimbursement rates for lab costs by up to 15%.
DYAX Investor Sentiment
Bullish (Long) 57% · Bearish (Short) 43%
461 participants
Related News
- SPCX Stock Gains 1% — SpaceXAI's Grok AI Agent Tops 400K Users As Meta's Muse Gains Popularity
- Michael Burry’s Memory Stocks Thesis Gets Fresh Support From Acer CEO’s Supply Warning
- JPMorgan Chase Falls 3% Despite New $20B QIA Partnership; Goldman Sachs Eases, Bank of America Slips
- CME Group to Launch Bitcoin Cash and Uniswap Futures
- Where Will SentinelOne (S) Stock Be in 3 Years?
- Big Short Investor Issues AI Warning: ‘70% of AI Revenue Is Just Two Companies, And One of Them I Think Is in Trouble’
